Trial intelligence / Profile preview

Dialysate Sodium in Hospitalized Hemodialysis Patients

NCT02145260Completed

Sponsor
Brigham and Women's Hospital
Start
Jul 2014
Primary completion
Dec 2020
Countries
1
01

Overview

Randomised, double-blind trial of sodium in intradialytic hypotension (IDH), sponsored by Brigham and Women's Hospital. Primary endpoint: Intra-dialytic Decline in Systolic Blood Pressure at 2 weeks. Started Jul 2014; status: completed.

02

Drugs

sodium
03

Conditions

intradialytic hypotension (IDH)

Beyond the preview

Go deeper on NCT02145260.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02145260.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call